SCHEMBL5809141

SCHEMBL5809141

C/C(=N\NC(=O)c1cc(Cl)c(O)c(Cl)c1)c1cccc(O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.65
MAPT P10636 5/20 0.65
KDM4E B2RXH2 1/20 0.65
NPC1 O15118 5/20 0.57
MTOR P42345 2/20 0.55
HTT P42858 1/20 0.53
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 3/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
POLB P06746 2/20 0.49
CASP6 P55212 2/20 0.49
MCL1 Q07820 1/20 0.49
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907770 0.79 HDAC8 (0.52) GAAMAPTNPC1MTORRAB9A
SCHEMBL4907784 0.79 HDAC8 (0.52) GAAMAPTNPC1MTORRAB9A
SCHEMBL4907788 0.79 HDAC8 (0.52) GAAMAPTNPC1MTORRAB9A
SCHEMBL4751701 0.78 MAPT (0.79) GAAMAPTKDM4ENPC1MTOR
SCHEMBL4751703 0.78 MAPT (0.79) GAAMAPTKDM4ENPC1MTOR
SCHEMBL10281920 0.74 KDM4E (0.67) GAAMAPTKDM4ENPC1MTOR
SCHEMBL683780 0.73 KDM1A (0.60) GAAMAPTMTORHTTRAB9A
SCHEMBL10143899 0.72 ESRRG (0.68) GAAMAPTKDM4ENPC1MTOR
SCHEMBL684551 0.72 KDM1A (0.70) GAAMAPTKDM4ENPC1RAB9A
SCHEMBL6635457 0.71 NPC1 (0.77) GAAMAPTNPC1MTORRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO claimed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed